Trial intelligence / Profile preview

Low Volume Ultrasound-Guided Interscalene Block for Shoulder Surgery

NCT00497354Phase 3Completed

Sponsor
Sunnybrook Health Sciences Centre
Start
Jul 2007
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of ropivacaine in pain, sponsored by Sunnybrook Health Sciences Centre. Primary endpoint: Diaphragmatic paresis. Started Jul 2007; status: completed.

02

Drugs

ropivacaine
03

Conditions

pain

Beyond the preview

Go deeper on NCT00497354.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00497354.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call